As for AD-MSCs and BM-MSCs, CBF-MSCs showed no expression of the hematopoietic markers CD34 and CD45, MHC class II maker HLA-DR, or B-lymphocyte antigen CD19. The gene discussed is HLA-C; the disease is Alzheimer disease.